Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
6.90
-0.64 (-8.49%)
Aug 28, 2026, 3:08 PM EDT - Market open
Niki BioSolutions Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
20.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 431.38K | -864.51K | -66.71% |
| Dec 31, 2022 | 1.30M | -245.89K | -15.95% |
| Dec 31, 2021 | 1.54M | 630.27K | 69.15% |
| Dec 31, 2020 | 911.51K | 376.34K | 70.32% |
| Dec 31, 2019 | 535.17K | 151.72K | 39.57% |
| Dec 31, 2018 | 383.45K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cerenome | 4.20M |
| Dyadic International | 3.80M |
| Marker Therapeutics | 3.55M |
| Longeveron | 1.19M |
| Allarity Therapeutics | 345.00K |
| Cocrystal Pharma | 330.00K |
NIKI News
- 9 hours ago - Niki BioSolutions files $75M mixed securities shelf - TheFly
- 6 weeks ago - Aptorum Group Provides Update on DiamiR Biosciences Merger - GlobeNewsWire
- 7 weeks ago - Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer's Association International Conference - GlobeNewsWire
- 2 months ago - Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers - GlobeNewsWire
- 2 months ago - Statement in Response to Silver Elephant's News Release Dated June 17, 2026 - Newsfile Corp
- 2 months ago - Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences - GlobeNewsWire
- 6 months ago - Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania - GlobeNewsWire
- 7 months ago - Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease - GlobeNewsWire